Tirzepatide × Skye Peptides - Lab Test, January 2025

This independent lab test from Janoshik Labs confirms Tirzepatide 60mg from Skye Peptides at 99.813% purity. The analysis was conducted on January 9, 2025, with tested quantity of 61.32mg. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. The high purity level of 99.813% indicates minimal contamination and high-grade synthesis quality. The tested quantity of 61.32mg exceeds the stated label claim of 60mg, demonstrating product integrity. The full certificate of analysis is available for verification on this page.